PAVMZ Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 18:10):
No signals from the correlation tool

Stats
Dagens volum	22 700
Gjennomsnittsvolum	0
Markedsverdi	6.66M
EPS	$-1.750 ( Q1 \| 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 43.86
ATR14	$0 (0.00%)

ABMD 0.00%

AMIX -2.65%

BBLGW -19.30%

BVS 0.55%

COCH 0.43%

DHAI -3.78%

DHAIW 0.00%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -2.26%

HSCSW 19.64%

IINNW -27.42%

INVO -6.67%

LFWD 0.49%

MDAI 1.81%

MGRM -2.86%

MXCT -2.57%

NVNOW -32.98%

NXL 25.13%

NXLIW -25.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ -4.76%

PETVW 0.00%

QTI 1.57%

QTNT 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-05-04	O'neil Shaun	Sell	25 935	Common stock
2022-02-22	O'neil Shaun	Sell	0	Common stock
2022-02-22	O'neil Shaun	Sell	195 108	Employee stock option (right to buy)
2022-02-22	O'neil Shaun	Sell	100 000	Employee stock option (right to buy)
2022-02-22	O'neil Shaun	Sell	75 000	Employee stock option (right to buy)

INSIDER POWER
100.00
Last 14 transactions
Buy: 2 950 000 \| Sell: 396 043

Korrelasjon (AI algo v.1.1b): Paired value (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

PAVmed Inc Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

PAVmed Inc Økonomi

Annual	2023
Omsetning:	$2.45M
Bruttogevinst:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2023
Omsetning:	$2.45M
Bruttogevinst:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2022
Omsetning:	$377 000
Bruttogevinst:	$-3.24M (-858.62 %)
EPS:	$-17.06

FY	2021
Omsetning:	$500 000
Bruttogevinst:	$-85 000.00 (-17.00 %)
EPS:	$-1.150

Financial Reports:

No articles found.

PAVmed Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PAVmed Inc

PAVmed Inc. operates as a medical device company in the United States. The company\'s lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett\'s Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.